Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study

BACKGROUND AND OBJECTIVE: Ciprofloxacin is a fluoroquinolone used for empirical and targeted therapy of a wide range of infections. Despite the increase in obesity prevalence, only very limited guidance is available on whether the ciprofloxacin dose needs to be adjusted when administered orally or i...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rhee, Koen P., Smit, Cornelis, Wasmann, Roeland E., van der Linden, Paul D., Wiezer, Rene, Van Dongen, Eric P. A., Krekels, Elke H. J., Brüggemann, Roger J. M., Knibbe, Catherijne A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349153/
https://www.ncbi.nlm.nih.gov/pubmed/35641862
http://dx.doi.org/10.1007/s40262-022-01130-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349153/
https://www.ncbi.nlm.nih.gov/pubmed/35641862
http://dx.doi.org/10.1007/s40262-022-01130-5

Ejemplares similares